CoChat

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

Open access
Dujic, T., Causevic, A., Bego, T., Malenica, M., Velija‐Asimi, Z., Pearson, E. R., Semiz, S. · 2016 · Diabetic Medicine
Cited by 136

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aims: Metformin is the most widely used oral anti‐diabetes agent and has considerable benefits over other therapies, yet 20–30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these side effects. The mechanism for gastrointestinal side effects and their considerable inter‐individual variability is unclear. We have recently shown the association between organic cation transporter 1 (OCT 1) variants and severe intolerance to metformin in people with Type 2 diabetes. The aim of this study was to explore the association of OCT 1 reduced‐function polymorphisms with common metformin‐induced gastrointestinal side effects in Type 2 diabetes. Methods: This prospective observational cohort study included 92 patients with newly diagnosed Type 2 diabetes, incident users of metformin. Patients were genotyped for two common loss‐of‐function variants in the OCT 1 gene (SLC 22A1): R61C (rs12208357) and M420del (rs72552763). The association of OCT 1 reduced‐function alleles with gastrointestinal side effects was analysed using logistic regression. Results: Forty‐three patients (47%) experienced gastrointestinal adverse effects in the first 6 months of metformin treatment. Interestingly, the number of OCT 1 reduced‐function alleles was significantly associated with over two‐fold higher odds of the common metformin‐induced gastrointestinal side effects (odds ratio = 2.31, 95% confidence interval 1.07–5.01, P = 0.034). Conclusions: In conclusion, we showed for the first time the association between OCT 1 variants and common metformin‐induced gastrointestinal side effects. These results confirm recent findings related to the role of OCT 1 in severe metformin intolerance, and suggest that high inter‐individual variability in mild/moderate and severe gastrointestinal intolerance share a common underlying mechanism. These data could contribute to more personalized and safer metformin treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.13040

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Dujic, T., Causevic, A., Bego, T., Malenica, M., Velija‐Asimi, Z., Pearson, E. R., & Semiz, S.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2015-12-24
Volume
33
Issue
4
Pages
511-514
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2181174026
Cited by
136
References
3
FWCI
11.45
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.